Opportunistic infections shortly after beginning highly active antiretroviral therapy

Antiviral Therapy

Volumn 3, Issue 4, 1998, Pages 229-231

  Rodríguez Rosado, Rafael ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL COUNT; COMORBIDITY; FEMALE; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INFLAMMATION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PATIENT CARE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE; RETINITIS; SPAIN; TOXOPLASMOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0032431452     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Torres R & Barr M. Impact of combination therapy for HIV infection on inpatient census. New England Journal of Medicine 1997; 336:1531-1532.
2. Hogg R, O'Shaughnessy M, Gataric N & Montaner J. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997; 349:1294.
3. Palella F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G, Aschman D, Holmberg S & The HIV Outpatient Study Investigators. New England Journal of Medicine 1998; 338:853-860.
4. Egger M, Hirschel B & Francioli P. Impact of new antiretroviral combination therapies in HIV-infected patients in Switzerland: a prospective multicentre study. British Medical Journal 1997; 315:1194-1199.
5. Soriano V, Rodríguez-Rosado R, Silva T & González-Lahoz J. Admissions and deaths in an HIV unit before and after introducing protease inhibitors. Revista Clínica Española 1998 (in press).
6. Hammer S, Squires K & Hughes M. A controlled trial of two nucleoside analogues plus indinavir in persons with HIV infection and CD4 cell counts of 200 per cubic millimeter or less. New England Journal of Medicine 1997; 337:725-733.
7. Carr A, Marriott D, Field A, Vasak E & Cooper D. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998; 351:256-261.
8. Grube H, Ramratnam B, Ley C &Flanigan TP. Resolution of AIDS associated cryptosporidiosis after treatment with indinavir. American Journal of Gastroenterology 1997; 92:726.
9. Goguel J, Katlama C, Sarfati C, Maslo C, Leport C & Molina JM. Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy. AIDS 1997; 11:1658-1659.
10. Elliot B, Aromin I, Gold R, Flanigan T & Mileno M. 2.5 year remission of AIDS-associated progressive multifocal leukencephalopathy with combined antiretroviral therapy. Lancet 1997; 349:850.
11. Blum L, Pellet C, Agbalika F, Blanchard G, Morel P, Calvo F & Lebbe C. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy. AIDS 1997; 11:1653-1655.
12. Conant MA, Opp KM, Poretz D & Mills RG. Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir. AIDS 1997; 11:1300-1301.
13. Parra R, Leal M, Delgado J, Macías J, Rubio A, Gomez F, Soriano V, Sanchez-Quijano A, Pineda JA & Lissen E. Regression of invasive AIDS-related Kaposi's sarcoma following antiretroviral therapy. Clinical Infections Diseases 1998; 26:218-219.
14. Whitcup S, Fortin E, Nussenblatt R, Polis M, Muccioli C & Belfort R Jr. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis. Journal of the American Medical Association 1997; 277:1519-1520.
15. Skolnick A. Protease inhibitors may reverse AIDS dementia. Journal of the American Medical Association C 1998; 279:419.